These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Nucleoside analogue-induced fatal lactic acidosis in two HIV-infected patients in Singapore. Hwang SW; Leo YS Singapore Med J; 2001 Jun; 42(6):247-51. PubMed ID: 11547960 [TBL] [Abstract][Full Text] [Related]
9. Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry. Tavassoli N; Bagheri H; Sommet A; Delpierre C; Marion-Latard F; Massip P; Aquilina C; Bonnet E; Obadia M; Labau E; Montastruc JL; Bernard J Pharmacotherapy; 2006 Feb; 26(2):154-61. PubMed ID: 16466321 [TBL] [Abstract][Full Text] [Related]
10. Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team. Raffi F; Reliquet V; Francois C; Garre M; Hascoet C; Allavena C; Arvieux C; Breux JP; Perre P; Rozenbaum W; Auger S Antivir Ther; 1998; 3 Suppl 4():57-60. PubMed ID: 10723512 [TBL] [Abstract][Full Text] [Related]
11. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy. Shah SS; Rodriguez T; McGowan JP Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors. Fitzgibbon JE; DiCola B; Arnold E; Das K; Sha BE; Pottage JC; Nahass R; Gaur S; John JF Antivir Ther; 2001 Dec; 6(4):231-8. PubMed ID: 11878404 [TBL] [Abstract][Full Text] [Related]
13. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion. Antoniou T; Weisdorf T; Gough K CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549 [TBL] [Abstract][Full Text] [Related]
14. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1. Krogstad P; Lee S; Johnson G; Stanley K; McNamara J; Moye J; Jackson JB; Aguayo R; Dieudonne A; Khoury M; Mendez H; Nachman S; Wiznia A; Clin Infect Dis; 2002 Apr; 34(7):991-1001. PubMed ID: 11880966 [TBL] [Abstract][Full Text] [Related]
15. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy]. MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158 [No Abstract] [Full Text] [Related]
16. Stavudine in antiretroviral therapy: is this the end? Brinkman K AIDS; 2009 Aug; 23(13):1727-9. PubMed ID: 19571724 [No Abstract] [Full Text] [Related]
17. Lactic acidosis and antiretroviral therapy: a case report and literature review. Marra A; Lewi D; Lanzoni V; Wey SB; Odashiro LN; Gomes PS; Silva E Braz J Infect Dis; 2000 Jun; 4(3):151-5. PubMed ID: 10934499 [TBL] [Abstract][Full Text] [Related]
18. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy. Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619 [TBL] [Abstract][Full Text] [Related]
19. Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study. Rutschmann OT; Opravil M; Iten A; Malinverni R; Vernazza PL; Bucher H; Bernasconi E; Perrin LH; Yerly S; Hirschel B Antivir Ther; 1998; 3 Suppl 4():65-7. PubMed ID: 10723515 [TBL] [Abstract][Full Text] [Related]
20. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]